HBx蛋白通过稳定WDR5蛋白介导H3K4me3修饰促进肝癌发生
本研究探讨表观遗传机制在HBV相关肝细胞癌中的作用,发现WDR5在HBV相关HCC中高表达并促进肿瘤发展。HBx通过抑制DDB1/CUL4与WDR5的相互作用减少WDR5泛素化,稳定WDR5蛋白,进而全基因组促进H3K4me3修饰和HBV转录。WDR5抑制剂WDR5-0103可抑制HBV及HBx驱动的肿瘤增殖和HBV转录,提示HBx-WDR5-H3K4me3轴是潜在治疗靶点。
要点
- WDR5在HBV相关HCC中高表达并促进肿瘤发展,是HBV诱导肿瘤发生的关键表观遗传决定因素。
- HBx通过抑制DDB1/CUL4与WDR5的相互作用减少WDR5泛素化,从而稳定WDR5蛋白。
- WDR5抑制剂WDR5-0103可抑制HBV及HBx驱动的肿瘤增殖和HBV转录。
核心结论
- WDR5是HBV诱导肿瘤发生的关键表观遗传决定因素,HBx-WDR5-H3K4me3轴可能是HBV诱导肝病发病机制的潜在治疗靶点。
研究设计与样本
- 基础研究,涉及小鼠模型、细胞实验及体外和体内数据。
主要发现
- WDR5在HBV相关HCC中高表达并促进HCC发展,在HBV驱动的细胞增殖和小鼠肿瘤生长中起关键作用。
- HBx通过抑制DDB1/CUL4与WDR5的相互作用减少WDR5泛素化,从而稳定WDR5蛋白。
- HBx与WDR5在全基因组染色质上共定位,并通过WDR5促进全基因组H3K4me3修饰。
- HBx通过其α-螺旋结构域与WDR5相互作用,依赖WDR5招募至靶基因启动子。
- WDR5通过cccDNA微染色体的H3K4修饰促进HBV转录,WDR5-0103可抑制HBV转录;HBx以WDR5依赖方式发挥促肿瘤功能。
关键数值与推荐
- WDR5-0103小分子抑制剂损害HBV和HBx驱动的肿瘤增殖。
- WDR5-0103能够抑制HBV转录。
临床怎么用
- WDR5-0103等WDR5活性抑制剂可能用于抑制HBV相关肝癌的肿瘤增殖和HBV转录。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Cancer is typically considered as a genetic and epigenetic disease. Although numerous studies have indicated that an aberrant structure, function, or expression level of epigenetic enzymes contribute to many tumor types, precisely how the epigenetic mechanisms are involved in the hepatitis B virus (HBV)-induced hepatocellular carcinoma (HCC) remains unknown. APPROACH AND RESULTS: In this study, we found that the WD repeat domain 5 protein (WDR5)-a core subunit of histone H3 lysine 4 methyltransferase complexes, which catalyze the generation of histone H3 lysine 4 trimethylation (H3K4me3) modification-is highly expressed in HBV-related HCC and promotes HCC development. WDR5 plays a critical role in HBV-driven cell proliferation and tumor growth in mice, and the WDR5-0103 small-molecule inhibitor of WDR5 activity compromises HBV- and hepatitis B x protein (HBx)-driven tumor proliferation. The aberrantly high WDR5 protein level was found to involve HBx through its stabilization of the WDR5 protein by inhibiting the interaction between the damage-specific DNA-binding protein 1/cullin-4 and WDR5, causing decreased ubiquitination of the WDR5 protein. HBx was found to colocalize with WDR5 on chromatin genome wide and promotes genome-wide H3K4me3 modification by means of WDR5. Furthermore, the recruitment of HBx to promoters of target genes relied on its interaction with WDR5 through its α-helix domain. WDR5 was also found to promote HBV transcription through H3K4 modification of covalently closed circular DNA minichromosome, and WDR5-0103 was able to inhibit HBV transcription. Finally, the in vitro and in vivo data further proved that HBx exerted its tumor-promoting function in a WDR5-dependent manner. CONCLUSIONS: Our data reveals that WDR5 is a key epigenetic determinant of HBV-induced tumorigenesis and that the HBx-WDR5-H3K4me3 axis may be a potential therapeutic target in HBV-induced liver pathogenesis.
引用
- Gao W, Jia Z, Tian Y, et al. HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 Protein. Hepatology. 2020. PMID: 31544250. doi:10.1002/hep.30947
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。